Skip to content

CHICAGO EQUITY PARTNERS LLC: ACIW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CHICAGO EQUITY PARTNERS LLC on ACIW, newest first. How the timeline and the estimate are built.

CHICAGO EQUITY PARTNERS LLC held 11,350 ACIW shares at 2020-03-31 per its 13F-HR filed 2020-05-06.

the latest 13F is the newest step

  1. period ended2020-03-31
    13F 11,350 shares
    Change vs previous 13F -35,290 shares

    0.03% of the 13F portfolio, value $274,000.

    13F-HR 0001221073-20-000092 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2019-12-31
    13F 46,640 shares
    Change vs previous 13F -28,690 shares

    0.1% of the 13F portfolio, value $1,767,000.

    13F-HR 0001085146-20-000514 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2019-09-30
    13F 75,330 shares
    Change vs previous 13F -92,715 shares

    0.11% of the 13F portfolio, value $2,360,000.

    13F-HR 0001085146-19-002673 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2019-06-30
    13F 168,045 shares
    Change vs previous 13F +154,620 shares

    0.26% of the 13F portfolio, value $5,771,000.

    13F-HR 0001085146-19-002053 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2019-03-31
    13F 13,425 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $441,000.

    13F-HR 0001085146-19-001514 filed by CHICAGO EQUITY PARTNERS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).